Qube Research & Technologies LTD Insmed Inc Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Insmed Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 389,033 shares of INSM stock, worth $30.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
389,033
Previous 489,307
20.49%
Holding current value
$30.2 Million
Previous $35.7 Million
24.81%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$985 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$552 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...